The United States has become preoccupied with the threat of bioterrorism. Dr. David Relman describes the important consequences for the biomedical research agenda, funding priorities, and the regulatory environment.
No takes yet. Share an insight, caveat, or question.
David A. Relman (2006) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: